alexa Evidence Supporting Efficacy: The Good Laboratory Practices Orphan
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference on Pharmaceutical Regulatory Affairs
October 21-23, 2013 DoubleTree by Hilton Hotel San Francisco Airport, CA, USA

L. Bruce Pearce
Accepted Abstracts: Pharmaceut Reg Affairs
DOI: 10.4172/2167-7689.S1.012
Abstract
The high failure rate (85-95%) for drugs and biologics during clinical testing is continuing to contribute to a steady decline in investment dollars for early stage development and inflation in overall development costs. The major reason for failure is not safety but rather failure to meet efficacy endpoints during clinical testing. A root cause is the poor quality of nonclinical studies supporting efficacy based on systematic reviews and high rate of failure (>75%) of pharma to reproduce published results. Regulatory guidance has established standards for toxicology/safety data derived from nonclinical testing including the requirement that key toxicology studies are performed in accordance with good laboratory practices (GLPs). Nonclinical data supporting the efficacy of a candidate therapeutic is treated as a GLP orphan. Ironically, these data are often the foundation upon which biotech companies or development programs are established, yet the first time efficacy is subjected to rigorous evaluation is in phase 2 clinical testing where failure can have devastating consequences. The state of affairs with nonclinical studies has been characterized as being equivalent to where clinical trials were half a century ago. We cannot test hypotheses regarding the basis for these failures until the studies are consistently designed, performed and reported according to gold standards/practices approaching that of clinical trials. This presentation will discuss the impact of high failure rates, root causes and steps that can be taken to mitigate failures. This presentation is important to all stakeholders including entrepreneurs, scientists, management and investors.
Biography
L. Bruce Pearce received his undergraduate training in Chemistry and Biology at the University of Massachusetts and doctoral training in Pharmacology at the State University of New York. He completed postdoctoral training within the Departments of Pharmacology at Yale School and Harvard Medical School. He has worked for >25 years in academia and industry and is currently Senior Consultant at Biologics Consulting Group. Drug development experience includes entrepreneurial ventures, oversight of pharmacology, toxicology, pharmacokinetic and physiologic research. Current research interests include preclinical and clinical study design, risk/benefit analysis, translational pharmacology and decision making in drug development.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords